Incomplete-penetrant hypertrophic cardiomyopathy <i>MYH7</i> G256E mutation causes hypercontractility and elevated mitochondrial respiration
Soah Lee(Sungkyunkwan University), Daniel Bernstein(Stanford University), Matthew C. Childers(University of Washington), David L. Mack(California Institute for Regenerative Medicine), Kerry Y. Kao(University of Washington), Orlando Chirikian(Cardiovascular Institute of the South), Brock Roberts(Allen Institute for Cell Science), Divya Pathak(Cardiovascular Institute of the South), James W.S. Jahng(Cardiovascular Institute of the South), Joseph C. Wu(Cardiovascular Institute of the South), James A. Spudich(Stanford University), Cheavar A. Blair(University of Kentucky), Beth L. Pruitt(University of California, Santa Barbara), Alison S. Vander Roest(University of Michigan), Samantha Bremner(University of Washington), Jacqueline E. Smith(Allen Institute for Cell Science), Ruwanthi N. Gunawardane(Allen Institute for Cell Science), Sean M. Wu(Cardiovascular Institute of the South), Michael Regnier(University of Washington), Paul V. Heinrich(Cardiovascular Institute of the South), Saffie Mohran(University of Washington), Kathleen M. Ruppel(Stanford University), Daniel Lee(Northwestern University), David T. Paik(Cardiovascular Institute of the South)
Cited by 13
Related Papers
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
|Nature Reviews Cardiology|2020|1.5k
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
|Science|2016|710
MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury
|Circulation Research|2017|243